刘晓智
个人简介
男,43岁,医学博士,副主任医师,天津市科技专家库第一批入库专家,国家自然科学基金项目评审专家,天津市“131”科技创新型人才第一层次人选,滨海新区五四青年奖章获得者。现任天津市第五中心医院中心实验室主任、天津市早产儿器官发育表观遗传重点实验室办公室主任、天津市医学重点建设学科(儿科)学科带头人;Frontiers in Cellular Neuroscience、Clinical Science (London)、《中华新生儿科杂志》等杂志评审专家。主要从事早产儿器官发育相关疾病的基础与临床研究。主持和参与国家自然科学基金项目9项,天津市科委项目7项,天津市卫健委及滨海新区科研项目20余项,总科研经费2000余万元;共发表学术论文208篇,其中SCI论文70篇;获得天津市科技成果11项。
主要研究方向
早产儿器官发育相关疾病的基础与临床
代表性学术成果
(1) Zhang Dianying, Yu Kai, Yang Zhong, Li Yanxia, Ma Xiaofang, Bian Xiyun, Liu Fengting, Li Lili, Liu Xiaozhi*, Wu Wenhan*. Silencing Ubc9 expression suppresses osteosarcoma tumorigenesis and enhances chemosensitivity to HSV-TK/GCV by regulating connexin 43 SUMOylation. Int J Oncol, 2018,53(3):1323-1331.
(2) Bian Xiyun., Xu Jingman., Zhao Huanhuan., Zheng Quan., Xiao Xiaolin., Ma Xiaofang., Li Yanxia., Du Xinping., Liu Xiaozhi*. Zinc-Induced SUMOylation of Dynamin-Related Protein 1 Protects the Heart against Ischemia-Reperfusion Injury. Oxidative Medicine and Cellular Longevity. 2019 Jul 22;2019:1232146. PubMed PMID: 31428220.
(3) Li M, Dong X, Chen S, Wang W, Yang C, Li B, Liang D, Yang W, Liu X*, Yang X*. Genetic polymorphisms and transcription profiles associated with intracranial aneurysm: a key role for NOTCH3. Aging (Albany NY). 2019 Jul 23;11(14):5173-5191.
(4) Kang Liang, Liu Shiwei, Li Jingchao, Tian Yueyang, Xue Yuan*, Liu Xiaozhi*. Parkin and Nrf2 prevent oxidative stress-induced apoptosis in intervertebral endplate chondrocytes via inducing mitophagy and anti-oxidant defenses.Life Sci. 2019 Dec 28;243:117244.
(5) Liang Kang, Shiwei Liu, Jingchao Li, Yueyang Tian, Yuan Xue*, Xiaozhi Liu*.The mitochondria-targeted anti-oxidant MitoQ protects against intervertebral disc degeneration by ameliorating mitochondrial dysfunction and redox imbalance.Cell Proliferation. 2020,53(3), e12779.
(6) Zhihao Liu#, Xiyun Bian#, Wenbo Gao, Jing Su, Chuanrui Ma, Xiaolin Xiao, Tian Yu, Han Zhang, Xiaozhi Liu*, Guanwei Fan*. Rg3 promotes the SUMOylation of SERCA2a and corrects cardiac dysfunction in heart failure. Pharmacological Research. 2021 Oct;172:105843.
(7) Xie Ying, Han Na, Li Feng, Wang Lijuan, Liu Gerui, Hu Meilin, Wang Sheng, Wei Xuelei, Guo Jing, Jiang Hongmei, Wang Jingjing, Li Xin, Wang Yixuan, Wang Jingya, Bian Xiyun, Zhu Zhongjiao, Zhang Hui, Liu Chunhua, Liu Xiaozhi*, Liu Zhiqiang*.Melatonin enhances osteoblastogenesis of senescent bone marrow stromal cells through NSD2-mediated chromatin remodelling. Clinical and Translational Medicine, 2022,12(2), e746.
(8) Liu Fengting, Ma Xiaofang, Bian Xiyun, Zhang Chunyan, Liu Xiaozhi*, Liu Qiang*.(2022). LINC00586 Represses ASXL1 Expression Thus Inducing Epithelial-To-Mesenchymal Transition of Colorectal Cancer Cells Through LSD1-Mediated H3K4me2 Demethylation. Front Pharmacol, 13(undefined), 887822.
(9) Wenyue Xie,Yanying Yin, Ruoheng Gu, Jingyue Xu, Xing Su, Yang Wang, Ruina Liu*, Xiaozhi Liu*, Jianyong Huang*,Label-free and highly selective MOFs-based dopamine detection in urine of Parkinson’s patients. Chemical Engineering Journal,2022,443:136371.
科研项目
已完成项目:
(1) 国家自然科学基金项目(面上项目)(81471175):SUMOs化温敏干细胞挽救脑缺血半暗带神经元的基础研究,1/2015-12/2018,70万元。
(2) 天津市自然科学基金项目(重点项目)(19JCZDJC35200):亚低温通过提高TET1 蛋白SUMO 化修饰机制增加NSCs干性维持潜能促进脑缺血后神经修复的研究,4/2019-3/2022,20万元。
在研项目:
(1) 天津市科技计划项目(22ZYQYSY00030):类器官研发与临床转化创新基地建设,1/2022-12/2023,200万元。
(2) 天津市卫生健康科技项目(TJWJ2022XK043):基于转基因鼠研究SUMO对早产儿重要器官发育的影响,2022.7-2025.06,50万元。
获奖情况
(1) 2018年入选天津市“131”科技创新型人才第一层次。
(2) 2018年入选天津市海河学者医学青年新锐。
(3) 2019年入选天津市科技专家库第一批入库专家。
社会学术兼职
(1) 世界神经外科协会联盟(WFNS)正式会员(2010.02-)
(2) 北京大学医学部神经外科学学系教授委员会委员(2018.04-)
(3) 天津市早产儿器官发育表观遗传重点实验室学术委员会秘书(2020.01-2023.12)
(4) 天津市滨海新区医学会常务理事(2022.01-)
(5) Frontiers in Pharmacology(IF:5.988)杂志评审专家
(6) 《中华新生儿科杂志》评审专家(2021.1.5-)